Document is current
Any future updates will be listed below
-
Authors
,
Manca, Antonella
,
,
Paliogiannis, Panagiotis
Colombino, Maria
Casula, Milena
Lissia, Amelia
Botti, Gerardo
Caracò, Corrado
Ascierto, Paolo A.
Sini, Maria Cristina
Palomba, Grazia
Pisano, Marina
Doneddu, Valentina
Cossu, Antonio
Palmieri, Giuseppe https://orcid.org/0000-0002-4350-2276
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (AIRC) "Programma di ricerca 5 per Mille 2018" (Id.21073)
- License Information
-
More Information
Article History
Received: 5 May 2019
Accepted: 18 August 2019
First Online: 28 August 2019
Ethics approval and consent to participate
: All the patients gave their informed consent for the anonymous use of their clinical data for the purposes of the study. The study was approved by the Committee for the Ethics of the Research and Bioethics of the National Research Council (CNR).
: Not applicable.
: Paolo A. Ascierto has/had a consultant and advisory role for Bristol Myers Squibb, Incyte, Merck Sharp & Dohme, Roche-Genentech, Novartis, Amgen, Array, Merck-Serono, and Pierre Fabre. He received research fund from Bristol Myers Squibb, Roche-Genetech, and Array. Giuseppe Palmieri has/had an advisory role for Bristol Myers Squibb, Incyte, Merck Sharp & Dohme, Novartis, Pierre Fabre, and Roche-Genetech. All the remaining authors declare no competing interests.
